Preclinical Characterization of 22-(4′-Pyridinecarbonyl) Jorunnamycin A against Lung Cancer Cell Invasion and Angiogenesis <i>via</i> AKT/mTOR Signaling

Iksen Iksen(Chulalongkorn University), Varisa Pongrakhananon(Chulalongkorn University)
ACS Pharmacology & Translational Science
July 25, 2023
Cited by 7


Related Papers